dofequidar has been researched along with Neoplasms in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Augustine, AM; Baranowska-Kortylewicz, J; Kortylewicz, ZP; McGarry, J; Nearman, J | 1 |
Bonneterre, J; Bonneterre, ME; Degardin, M; DiƩras, V; Fumoleau, P; Lacombe, D; Laurence, V; Marreaud, S; Pierga, JY | 1 |
Ahmad, K | 1 |
Naito, M; Nakanishi, O; Tsuruo, T | 1 |
Turuo, T | 1 |
2 review(s) available for dofequidar and Neoplasms
Article | Year |
---|---|
[Overcoming of multidrug resistance by a newly synthesized quinoline compound, MS-209].
Topics: Animals; Antineoplastic Agents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Mice; Neoplasms; Quinolines; Tumor Cells, Cultured | 1997 |
[Targeted immunotherapy for malignant tumors].
Topics: Antineoplastic Agents; Apoptosis; Caspases; Drug Resistance, Neoplasm; Humans; Immunotoxins; Neoplasms; Quinolines; Tumor Cells, Cultured | 1999 |
1 trial(s) available for dofequidar and Neoplasms
Article | Year |
---|---|
Phase I combining a P-glycoprotein inhibitor, MS209, in combination with docetaxel in patients with advanced malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Prospective Studies; Quinolines; Taxoids; Treatment Outcome | 2005 |
2 other study(ies) available for dofequidar and Neoplasms
Article | Year |
---|---|
Radioiodinated agents for imaging multidrug resistant tumors.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Hydrophobic and Hydrophilic Interactions; Iodine Radioisotopes; Mice; Mice, Nude; Molecular Structure; Neoplasms; Quinolines; Radionuclide Imaging; Radiopharmaceuticals; Temperature; Time Factors; Tissue Distribution; Verapamil | 2009 |
Inhibitor of P-glycoprotein increases chemosensitivity.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Humans; Neoplasms; Quinolines | 2007 |